Second Affiliated Hospital, Zhejiang University, School of Medicine
The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS). The study included patients with 4A nodules confirmed by core biopsy and/or surgery. The CEUS parameters were assessed to evaluated the added value in BI-RADS 4A nodules
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients with nodules which were sonographically classified as BI-RADS 4 A breast lesion
You may not be if
(i) absence of a pathologic diagnosis; (ii) presence of breast nodules that were too large to compare with normal parenchyma; (iii) patients with radiotherapy and chemotherapy of breast cancer; and (iv) skin disorders.
Clareo Health | Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules
